ATHE Neutral Sentiment
ASX ANNOUNCEMENT 29 November 2023 Notice Under Section 708A(5)(e) of the Corporations Act This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), unde
Wednesday, November 29, 2023 BiopharmaWatch Research 1 min read Key Takeaway: Alterity Therapeutics Limited has issued a notice under section 708A(5)(e) of the Corporations Act regarding the issuance of fully paid ordinary shares. On 29 November 2023, the company issued 362,462,762 shares as noted in their official communication. This announcement serves as compliance with the regulatory disclosure requirements under Australian law. The shares are identified under the ASX code ATH.
Full Press Release Details
Notice Under Section 708A(5)(e)
This notice is given by Alterity
Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under section 708A(5)(e)
of the Corporations Act 2001 (Cth) (Corporations Act).
| Details of securities issued |
| Type | Shares |
| Class/Description | Fully paid ordinary shares |
| ASX Code | ATH |
| Date of Issue | 29 November 2023 |
| Number Issued | 362,462,762 |
The Company gives notice pursuant to
section 708A(5)(e) of the Corporations Act that:
Alterity Therapeutics Limited ACN
Level 3, 62 Lygon Street Carlton